People living with cystic fibrosis (CF) in Saskatchewan now have access to a new medication that can be life-changing. CF is a genetic disease that damages the lungs and digestive system. There is no ...

Supportive therapy, like medications to help open the airways and heal infections, can help you live a healthier life and meet many of the challenges of this inherited respiratory condition. Share on ...

The European Medicines Agency (EMA) recommended in its April meetings approval of marketing authorizations for two orphan medicines: Alyftrek for the treatment of cystic fibrosis and Attrogy for the ...

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung function ...

The Cystic Fibrosis Therapeutics Market is expected to reach US$ 16.78 billion in 2033 from US$ 7.70 billion in 2024, with a CAGR of 9.04% from 2025 to 2033. Advances in gene therapy, CFTR modulators, ...

Cystic fibrosis was once a dire, likely deadly diagnosis, destroying a patient's ability to breathe and digest food—but a revolutionary new treatment offers reason for hope. And on Thursday the three ...

Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...